Expert Columns by Sheela Ranganathan - O'Neill : O'Neill

Opinion & Analysis

November 20, 2024

Pharmaceutical Industry Seeks to Thwart State Initiatives to Tackle Unaffordability of Prescription Drugs

Opinion & Analysis

May 8, 2024

Threats to EMTALA: Unpacking the Oral Arguments in Idaho v. United States

Opinion & Analysis

March 7, 2024

No Surprises Act Litigation: Where We Are and What Comes Next

Opinion & Analysis

February 1, 2024

Unpacking Recent Antitrust Challenges to Private Equity in Health Care

Opinion & Analysis

November 20, 2023

Latest Development in Legal Challenges to Arbitration Process Under No Surprises Act

Sheela Ranganathan Former Associate

The Latest

Press Release

September 25, 2025

The O’Neill Institute Announces Retirement of Lawrence O. Gostin, Most Cited Professor in Health Law, As Co-Faculty Director

Statement

September 24, 2025

Statement from O’Neill Institute Directors Dr. Charles B. Holmes and Jeffrey S. Crowley on Landmark Agreement to Expand Access to Lenacapavir

Opinion & Analysis

September 18, 2025

Institutional Obstacles to Reforming Brazil’s Wholesale Food Markets